{ "items" : [
    { "id" : "http://dbpedia.org/resource/Panitumumab"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).Panitumumab is manufactured by Amgen and marketed as Vectibix.  It was originally developed by Abgenix Inc.In 2014, Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab." ] ,
        "http://dbpedia.org/ontology/atcPrefix" : [ "L01" ] ,
        "http://dbpedia.org/ontology/atcSuffix" : [ "XC08" ] ,
        "http://dbpedia.org/ontology/casNumber" : [ "339177-26-3" ] ,
        "http://dbpedia.org/ontology/drugbank" : [ "DB01269" ] ,
        "http://dbpedia.org/ontology/fdaUniiCode" : [ "6A901E312A"] } } }
